These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. [Application of flow cytometric immunophenotypic analysis in the diagnosis of malignant lymphoma]. Ren LQ; Xue LY; Bi R; Liang JM; Lin DM; Ma J; Lü N Zhonghua Xue Ye Xue Za Zhi; 2007 Oct; 28(10):671-6. PubMed ID: 18399172 [TBL] [Abstract][Full Text] [Related]
44. Clinical features and diagnosis of primary central nervous system lymphoma. Fitzsimmons A; Upchurch K; Batchelor T Hematol Oncol Clin North Am; 2005 Aug; 19(4):689-703, vii. PubMed ID: 16083830 [TBL] [Abstract][Full Text] [Related]
45. Application of dynamic contrast-enhanced MRI to differentiate malignant lymphoma from squamous cell carcinoma in the head and neck. Asaumi J; Yanagi Y; Konouchi H; Hisatomi M; Matsuzaki H; Kishi K Oral Oncol; 2004 Jul; 40(6):579-84. PubMed ID: 15063385 [TBL] [Abstract][Full Text] [Related]
47. [Molecular-genetic approach to the diagnosis of malignant lymphoma]. Novik AA; Belokhvostov AS Vopr Onkol; 1998; 44(3):274-9. PubMed ID: 9695770 [No Abstract] [Full Text] [Related]
48. [Clinical problems in the treatment of primary central nervous system malignant lymphoma]. Keyaki A; Nabeshima S; Hashimoto S; Waga S No To Shinkei; 2000 Sep; 52(9):781-7. PubMed ID: 11064864 [TBL] [Abstract][Full Text] [Related]
49. [Relevance of magnetic resonance imaging for the staging and follow up of lymph node pathologies in adults with primary malignant lymphomas]. Michna G; Ghanem N; Laubenberger J; Schneider B; Kromeier J; Langer M Radiologe; 2002 Dec; 42(12):993-9. PubMed ID: 12486553 [TBL] [Abstract][Full Text] [Related]
50. Loss to follow-up of patients with malignant lymphoma. Brown S; Belgaumi A; Ajarim D; Kofide A; Al-Saad R; Sabbah R; Ezzat A; Shoukri M; Barr R; Levin A Eur J Cancer Care (Engl); 2004 May; 13(2):180-4. PubMed ID: 15115474 [TBL] [Abstract][Full Text] [Related]
51. [Nursing assessment and nursing keypoints at admission of patients with malignant lymphoma]. Fukuda H; Shikamura M Kango Gijutsu; 1982 Jul; 28(9):1153-8. PubMed ID: 6923008 [No Abstract] [Full Text] [Related]
52. [Macrophage electrophoretic mobility inhibition test (MET) in immunological diagnosis of malignant lymphomas in Papio baboons]. Indzhiia LV; Iakovleva LA; Lapin BA; Tsaturian TN; Malkovskiĭ M Vopr Onkol; 1980; 26(11):66-71. PubMed ID: 7456428 [TBL] [Abstract][Full Text] [Related]
53. Highlights in Lymphoma From the 13th International Conference on Malignant Lymphoma. A Review of Selected Presentations From the 13th International Conference on Malignant Lymphoma • June 17-20, 2015 • Lugano, Switzerland. Moskowitz CH Clin Adv Hematol Oncol; 2015 Aug; 13(8 Suppl 9):1-23. PubMed ID: 26452080 [No Abstract] [Full Text] [Related]
55. [Organization of the diagnosis and treatment of malignant lymphoma in childhood]. Preibisch-Effenberger R; Kluba U; Kluba J; Mittler U Otolaryngol Pol; 1986; 40(1):17-20. PubMed ID: 3725385 [No Abstract] [Full Text] [Related]